Artificial pancreas trial for adults with type 1 diabetes
Part of Hormones & metabolism, Immune system & allergy clinical trials.
This trial tests a hybrid closed-loop system that automatically adjusts insulin delivery. It may help you manage your blood sugar more easily if you currently give yourself daily insulin shots.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have had type 1 diabetes for at least 1 year
- You have been taking insulin by injections (multiple daily shots) for at least 6 months
- Your most recent A1c is 7.0% or higher
- You use at least 10 units of insulin per day
- You are willing to use only lispro or aspart insulin during the trial
- You do not currently use an insulin pump or a closed-loop system
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial helps children with type 1 diabetes get advanced diabetes technology, aiming to reduce gaps in access for families with fewer resources. It will check whether these tools are usable and helpful for diabetes care in children who meet the study needs.
This study tests a new automated insulin delivery (AID) system that connects your insulin pump to your glucose monitor to help keep your blood sugar in range. It is for both children and adults with type 1 diabetes who have not used an AID system before.
This trial is testing a new automated insulin pump system that talks to your smartphone and lets the care team check on you from home. It helps people with type 1 diabetes better manage their blood sugar without extra trips to the clinic.
This study tests an upgraded automated insulin pump system that uses artificial intelligence to better predict and prevent blood sugar swings. If you have Type 1 Diabetes and already use an automated insulin pump, this trial may help you achieve better blood sugar control.
This study tests a system that measures blood sugar and automatically adjusts insulin delivery. It is for adults with type 1 diabetes who use insulin injections or a pump.
This study tests a smart insulin pump and continuous glucose monitor system that adjusts insulin automatically and uses behavior support to improve blood sugar control. It's for people with type 1 diabetes who have used an approved automated insulin delivery system recently and are willing to use study devices.
Hear when a new Diabetes Complications trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.